Not an actual patient.
Unique in situ polymeric extended-release delivery system enables sustained and controlled release of leuprolide acetate as it safely biodegrades1
leuprolide acetate
PLG copolymer
N-methyl-2-pyrrolidone (NMP)
ELIGARD being injected into SC tissue and solidifying in situ.
ELIGARD in situ, slowly biodegrading over the dosing period.
Inject ELIGARD at a 90° angle into subcutaneous tissue
ELIGARD is a refrigerated product and should be stored at 2 °C to 8 °C (36-45 °F) but can be left at room temperature for up to 8 weeks (56 days) prior to mixing and administration2
If the product is NOT administered within 30 minutes of mixing, it must be discarded2
ELIGARD may impair fertility in males of reproductive potential.